KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Total Liabilities (2016 - 2025)

Astrana Health (ASTH) has disclosed Total Liabilities for 15 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 97.49% to $1.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Dec 2025, up 97.49% year-over-year, with the annual reading at $1.7 billion for FY2025, 97.49% up from the prior year.
  • Total Liabilities hit $1.7 billion in Q4 2025 for Astrana Health, down from $1.7 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.7 billion in Q3 2025 to a low of $346.1 million in Q3 2021.
  • Historically, Total Liabilities has averaged $659.4 million across 5 years, with a median of $452.3 million in 2022.
  • Biggest five-year swings in Total Liabilities: fell 14.03% in 2021 and later surged 116.18% in 2025.
  • Year by year, Total Liabilities stood at $356.7 million in 2021, then increased by 14.28% to $407.7 million in 2022, then grew by 28.19% to $522.6 million in 2023, then soared by 60.88% to $840.7 million in 2024, then soared by 97.49% to $1.7 billion in 2025.
  • Business Quant data shows Total Liabilities for ASTH at $1.7 billion in Q4 2025, $1.7 billion in Q3 2025, and $904.4 million in Q2 2025.